Tufts Medicine downgraded 2 notches as operating losses continue

“Significantly elevated” operating losses at Burlington, Mass.-based Tufts Medicine have resulted in the system having credit ratings downgraded two notches to “BBB-” from “BBB+,” S&P Global said Sept. 14.

Advertisement

The downgrades apply to various sets of bonds. The system was removed from CreditWatch negative where it was placed Aug. 3, while the outlook remains negative.

“The negative outlook incorporates the possibility that management’s turnaround efforts could be insufficient to offset various industry pressures resulting in a continued trend of heightened operating losses and limited balance sheet recovery,” the S&P note said.

Tufts Medicine employs more than 13,000 people and has a total of 1,116 licensed beds, according to its website.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.